The treatment of early breast cancer in women over the age of 70

British Journal of Cancer

Volumn 105, Issue 2, 2011, Pages 189-193

  Ring, A ^a   Reed, M ^b   Leonard, R ^c   Kunkler, I ^d   Muss, H ^e   Wildiers, H ^f   Fallowfield, L ^g   Jones, A ^h   Coleman, R ^b  

^a ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c CHARING CROSS HOSPITAL   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

^f UNIVERSITY OF LEUVEN   (Belgium)

^g BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^h ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

breast cancer; elderly; geriatric oncology

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; BISPHOSPHONIC ACID DERIVATIVE; CAPECITABINE; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; IBANDRONIC ACID; METHOTREXATE; PACLITAXEL; TAMOXIFEN; TRASTUZUMAB;

ADJUVANT THERAPY; AGE DISTRIBUTION; AGING; AXILLARY LYMPH NODE; BONE DENSITY; BREAST CANCER; BREAST RECONSTRUCTION; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CARDIOTOXICITY; CLINICAL TRIAL; DISEASE FREE SURVIVAL; EARLY CANCER; ESTHETIC SURGERY; GENE EXPRESSION; HEART DISEASE; HUMAN; LIFE EXPECTANCY; LYMPH NODE DISSECTION; MULTIPLE CYCLE TREATMENT; OSTEOLYSIS; OSTEOPOROSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; REVIEW; SIDE EFFECT;

AGE FACTORS; AGE OF ONSET; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MASTECTOMY; NEOADJUVANT THERAPY; NEOPLASM STAGING;

EID: 79960280175     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.234     Document Type: Review

References (32)

1. Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists' Group (2008) Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncol 9: 45-53
2. Bouchardy C, Rapiti E, Blagojevic S, Vlastos A-T, Vlastos G (2007) Older female cancer patients: importance, causes, and consequences of undertreatment. J Clin Oncol 25(14): 1858-1869 (Pubitemid 46854419)
3. Cancer Research UK (2010) Breast cancer-UK incidence statistics, accessed 22nd September 2010. Available at http://info.cancerresearchuk. org
4. Citron ML, Berry DA, Cirrincione C, Hudis C, Winer EP, Gradishar WJ, Davidson NE, Martino S, Livingston R, Ingle JN, Perez EA, Carpenter J, Hurd D, Holland JF, Smith BL, Sartor CI, Leung EH, Abrams J, Schilsky RL, Muss HB, Norton L (2003) Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of intergroup trial C9741/Cancer and Leukemia Group B Trial 9741. J Clin Oncol 21: 1431-1439 (Pubitemid 46594092)
5. Crivellari D, Sun Z, Coates AS, Price BN, Thürlimann B, Mouridsen H, Mauriac L, Forbes JF, Paridaens RJ, Castiglione-Gertsch M, Gelber RD, Colleoni M, Láng I, Del Mastro L, Gladieff L, Rabaglio M, Smith IE, Chirgwin JH, Goldhirsch A (2008) Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: The BIG 1-98 Trial. J Clin Oncol 26: 1972-1979
6. Extermann M, Hurria A (2007) Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol 25: 1824-1831 (Pubitemid 46860271)
7. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2005a) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366: 2087-2106
8. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2005b) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365: 1687-1717
9. Fleissig A, Fallowfield LJ, Langridge CI, Johnson L, Newcombe RG, Dixon JM, Kissin M, Mansel RE (2006) Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 95: 279-293
10. Hind D, Wyld L, Reed MW (2007) Surgery, with or without tamoxifen, vs tamoxifen alone for older women with operable breast cancer: Cochrane review. Br J Cancer 96: 1025-1029 (Pubitemid 46608304)
11. Hughes KS, Schnaper LA, Cirrincione C, Berry DA, McCormick B, Muss HB, Shank B, Hudis C, Winer EP, Smith BL (2010) Lumpectomy plus tamoxifen with or without irradiation in women age 70 or older with early breast cancer. J Clin Oncol 28: 507
12. International Breast Cancer Study Group (1996) Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of international breast cancer study group trial 10-93. J Clin Oncol 24: 337-344
13. Jones SE, Holmes F, O'Shaughnessy J, Blum J, Vukelaj S, McIntyre K, Pippen J (2007) Extended follow-up and analysis by age of the US Oncology Adjuvant trial 9735: docetaxel/cyclophosphamide is associated with an overall survival benefit compared to doxorubicin/cyclopho-sphamide and is well-tolerated in women 65 or older. Breast Cancer Res Treat 106: S5. Abstract 12
14. Kunkler I (2004) PRIME II breast cancer trial. Clin Oncol (R Coll Radiol) 16: 447-448 (Pubitemid 39232940)
15. Lavelle K, Todd C, Moran A, Howell A, Bundred N, Campbell M (2007) Non-standard management of breast cancer increases with age in the UK: a population based cohort of women X65 years. Br J Cancer 96: 1197-1203 (Pubitemid 46625077)
16. Lewis JH, Kilgore ML, Goldman DP, Trimble EL, Kaplan R, Montello MJ, Housman MG, Escarce JJ (2003) Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 21: 1383-1389 (Pubitemid 46606420)
17. Muss HB, Berry DA, Cirrincione CT, Theodoulou M, Mauer AM, Kornblith AB, Partridge AH, Dressler LG, Cohen HJ, Becker HP, Kartcheske PA, Wheeler JD, Perez EA, Wolff AC, Gralow JR, Burstein HJ, Mahmood AA, Magrinat G, Parker BA, Hart RD, Grenier D, Norton L, Hudis CA, Winer EP (2009) Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med 360: 2055-2065
18. Muss HB, Woolf S, Berry D, Cirrincione C, Weiss RB, Budman D, Wood WC, Henderson IC, Hudis C, Winer E, Cohen H, Wheeler J, Norton L (2005) Adjuvant chemotherapy in older and younger women with lymph-node positive breast cancer. JAMA 293: 1073-1081 (Pubitemid 40300281)
19. Mustacchi G, Cazzaniga ME, Pronzato P, De Matteis A, Di Costanzo F, Floriani I (2007) Breast cancer in elderly women: a different reality? Results from the NORA study. Ann Oncol; 18: 991-996 (Pubitemid 47050489)
20. NHS Information Centre (2010) National mastectomy and breast reconstruction audit (2010). A national audit of provision and outcomes of mastectomy and breast reconstruction surgery for women in England Second Annual Report 2009
21. Office for National Statistics (2010) Current interim life tables: United Kingdom (2006-2008). Accessed 30 June 2010. Available at http://www.statistics. gov.uk/statbase
22. Pinder MC, Duan Z, Goodwin JS, Hortobagyi GN, Giordano SH (2007) Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer. JCO 25: 3808-3815 (Pubitemid 47477254)
23. Reid DM, Doughty J, Eastell R, Heys SD, Howell A, McClosky EV, Powles T, Selby P, Coleman RE (2008) Guidance for breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group. Cancer Treat Rev 34: S3-S18
24. Romond EH, Perez EA, Bryant J, Suman VJ, Geyer Jr CE, Davidson NE, Tan-Chiu E, Martino S, Paik S, Kaufman PA, Swain SM, Pisansky TM, Fehrenbacher L, Kutteh LA, Vogel VG, Visscher DW, Yothers G, Jenkins RB, Brown AM, Dakhil SR, Mamounas EP, Lingle WL, Klein PM, Ingle JN, Wolmark N (2005) Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 353: 1673-1684 (Pubitemid 41464706)
25. Sandison AJP, Gold DM, Wright P, Jones PA (1996) Breast conservation or mastectomy: treatment choice of women age 70 years or older. Br J Surg 83: 994-996 (Pubitemid 26228227)
26. Schonberg MA, Marcantonio ER, Li D, Silliman RA, Ngo L, McArthy EP (2010) Breast cancer among the oldest old: tumor characteristics, treatment choices and survival. J Clin Oncol 28: 2038-2045
27. Smith IE, Procter M, Gelber R, Piccart-Gebhart M (2007) Trastuzumab after adjuvant chemotherapy in older patients. Lancet 369: 991-992 (letter) (Pubitemid 46436146)
28. START Trialist's Group (2008) The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 371: 1098-1107
29. Suter TM, Procter M, van Veldhuisen DJ, Muscholl M, Bergh J, Carlomagno C, Perren T, Passalacqua R, Bighin C, Klijn JG, Ageev FT, Hitre E, Groetz J, Iwata H, Knap M, Gnant M, Muehlbauer S, Spence A, Gelber RD, Piccart-Gebhart MJ (2007) Trastuzumab-associated cardiac adverse events in the Herceptin Adjuvant Trial. J Clin Oncol 25: 3859-3865 (Pubitemid 47477261)
30. Van Poznak C, Hannon RA, Mackey JR, Campone M, Apffelstaedt JP, Clack G, Barlow D, Makris A, Eastell R (2010) Prevention of aromatase inhibitor-induced bone loss using risedronate: the SABRE trial. J Clin Oncol 28: 967-975
31. Whelan TJ, Pignol JP, Levine MN, Julian JA, MacKenzie R, Parpia S, Shelley W, Grimard L, Bowen J, Lukka H, Perera F, Fyles A, Schneider K, Gulavita S, Freeman C (2010) Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 362: 513-520
32. Wyld L, Reed M (2007) The role of surgery in the management of older women with breast cancer. Eur J Cancer 43: 2253-2263 (Pubitemid 47539122)